{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:50:17Z","timestamp":1791039017174,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.neuropharm.2004.08.020","type":"journal-article","created":{"date-parts":[[2004,11,3]],"date-time":"2004-11-03T12:09:41Z","timestamp":1099483781000},"page":"1180-1188","source":"Crossref","is-referenced-by-count":82,"title":["Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER\u03b1 agonist"],"prefix":"10.1016","volume":"47","author":[{"given":"Myreille","family":"D\u2019Astous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuropharm.2004.08.020_BIB1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/(SICI)1097-4547(19991215)58:6<815::AID-JNR8>3.0.CO;2-R","article-title":"Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin-like growth factor-I signalling","volume":"58","author":"Azcoitia","year":"1999","journal-title":"J. Neurosci. Res"},{"issue":"9","key":"10.1016\/j.neuropharm.2004.08.020_BIB2","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.55.9.1358","article-title":"Parkinson\u2019s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian longitudinal study on aging","volume":"55","author":"Baldereschi","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neuropharm.2004.08.020_BIB3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/mol.51.4.535","article-title":"Neuroprotection against oxidative stress by estrogens: structure\u2013activity relationship","volume":"51","author":"Behl","year":"1997","journal-title":"Mol. Pharmacol"},{"issue":"5","key":"10.1016\/j.neuropharm.2004.08.020_BIB4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s004290050236","article-title":"Estrogen and the developing mammalian brain","volume":"199","author":"Beyer","year":"1999","journal-title":"Anat. Embryol. (Berl.)"},{"issue":"1","key":"10.1016\/j.neuropharm.2004.08.020_BIB5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/cne.1129","article-title":"Reactive astrocytes express estrogen receptors in the injured primate brain","volume":"433","author":"Blurton-Jones","year":"2001","journal-title":"J. Comp. Neurol"},{"issue":"4","key":"10.1016\/j.neuropharm.2004.08.020_BIB6","first-page":"779","article-title":"Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester","volume":"47","author":"Boja","year":"1995","journal-title":"Mol. Pharmacol"},{"issue":"14","key":"10.1016\/j.neuropharm.2004.08.020_BIB7","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2004.08.020_BIB8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1098-2396(20000915)37:4<245::AID-SYN1>3.0.CO;2-5","article-title":"Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice","volume":"37","author":"Callier","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2004.08.020_BIB9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/syn.1067","article-title":"Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl\/6 mice","volume":"41","author":"Callier","year":"2001","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.neuropharm.2004.08.020_BIB10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jnen\/61.2.186","article-title":"Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias","volume":"61","author":"Calon","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.neuropharm.2004.08.020_BIB11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-2952(97)00192-5","article-title":"Effects of a chronic lithium treatment on central dopamine neurotransporters","volume":"54","author":"Carli","year":"1997","journal-title":"Biochem. Pharmacol"},{"issue":"11","key":"10.1016\/j.neuropharm.2004.08.020_BIB12","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/en.138.11.4613","article-title":"Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse","volume":"138","author":"Couse","year":"1997","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.neuropharm.2004.08.020_BIB13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/syn.10145","article-title":"Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice","volume":"47","author":"D\u2019Astous","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2004.08.020_BIB14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1749-6632.2000.tb05189.x","article-title":"Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system","volume":"914","author":"Dluzen","year":"2000","journal-title":"Ann. N. Y. Acad. Sci"},{"issue":"6","key":"10.1016\/j.neuropharm.2004.08.020_BIB15","first-page":"36","article-title":"Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson\u2019s disease","volume":"3","author":"Dluzen","year":"2000","journal-title":"J. Gend. Specif. Med"},{"issue":"2","key":"10.1016\/j.neuropharm.2004.08.020_BIB16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0892-0362(02)00187-3","article-title":"Methamphetamine-gonadal steroid hormonal interactions: effects upon acute toxicity and striatal dopamine concentrations","volume":"24","author":"Dluzen","year":"2002","journal-title":"Neurotoxicol. Teratol"},{"issue":"15","key":"10.1016\/j.neuropharm.2004.08.020_BIB17","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1523\/JNEUROSCI.19-15-06385.1999","article-title":"Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors","volume":"19","author":"Dubal","year":"1999","journal-title":"J. Neurosci"},{"issue":"4","key":"10.1016\/j.neuropharm.2004.08.020_BIB18","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1073\/pnas.041483198","article-title":"Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury","volume":"98","author":"Dubal","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2004.08.020_BIB19","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"issue":"1","key":"10.1016\/j.neuropharm.2004.08.020_BIB20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0301-0082(00)00025-3","article-title":"Neuroprotection by estradiol","volume":"63","author":"Garcia-Segura","year":"2001","journal-title":"Prog. Neurobiol"},{"issue":"2","key":"10.1016\/j.neuropharm.2004.08.020_BIB21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001756-200002070-00024","article-title":"Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice","volume":"11","author":"Grandbois","year":"2000","journal-title":"Neuroreport"},{"issue":"4\u20136","key":"10.1016\/j.neuropharm.2004.08.020_BIB22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0960-0760(97)00124-6","article-title":"Phenolic A ring requirement for the neuroprotective effects of steroids","volume":"63","author":"Green","year":"1997","journal-title":"J. Steroid Biochem. Mol. Biol"},{"issue":"1","key":"10.1016\/j.neuropharm.2004.08.020_BIB23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/en.142.1.400","article-title":"The nonfeminizing enantiomer of 17beta-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia","volume":"142","author":"Green","year":"2001","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2004.08.020_BIB24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0303-7207(03)00255-7","article-title":"Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression","volume":"206","author":"Harrington","year":"2003","journal-title":"Mol. Cell. Endocrinol"},{"issue":"3","key":"10.1016\/j.neuropharm.2004.08.020_BIB25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/en.138.3.863","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2004.08.020_BIB26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0169-328X(03)00088-3","article-title":"Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol-kinase in the adult rat brain","volume":"112","author":"Mendez","year":"2003","journal-title":"Brain Res. Mol. Brain Res"},{"issue":"24","key":"10.1016\/j.neuropharm.2004.08.020_BIB27","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1021\/jm010254a","article-title":"Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues","volume":"44","author":"Meyers","year":"2001","journal-title":"J. Med. Chem"},{"issue":"5","key":"10.1016\/j.neuropharm.2004.08.020_BIB28","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/en.2002-221069","article-title":"Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha","volume":"144","author":"Mitra","year":"2003","journal-title":"Endocrinology"},{"issue":"16","key":"10.1016\/j.neuropharm.2004.08.020_BIB29","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1073\/pnas.96.16.8867","article-title":"The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties","volume":"96","author":"Moosmann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2004.08.020_BIB30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0039-128X(98)00092-0","article-title":"Estrogen: mechanisms for a rapid action in CA1 hippocampal neurons","volume":"64","author":"Moss","year":"1999","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.neuropharm.2004.08.020_BIB31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-5793(96)00782-X","article-title":"ER beta: identification and characterization of a novel human estrogen receptor","volume":"392","author":"Mosselman","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuropharm.2004.08.020_BIB32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.physiol.63.1.165","article-title":"Role of estrogen receptor beta in estrogen action","volume":"63","author":"Pettersson","year":"2001","journal-title":"Annu. Rev. Physiol"},{"issue":"10","key":"10.1016\/j.neuropharm.2004.08.020_BIB33","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1210\/me.11.10.1486","article-title":"Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha","volume":"11","author":"Pettersson","year":"1997","journal-title":"Mol. Endocrinol"},{"issue":"4","key":"10.1016\/j.neuropharm.2004.08.020_BIB34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/frne.1996.0011","article-title":"Membrane sex-steroid receptors in the brain","volume":"17","author":"Ramirez","year":"1996","journal-title":"Front. Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.neuropharm.2004.08.020_BIB35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000070277","article-title":"Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice","volume":"77","author":"Ramirez","year":"2003","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.neuropharm.2004.08.020_BIB36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1210\/me.13.2.307","article-title":"Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells","volume":"13","author":"Razandi","year":"1999","journal-title":"Mol. Endocrinol"},{"issue":"1","key":"10.1016\/j.neuropharm.2004.08.020_BIB37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/ENDO:21:1:81","article-title":"Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?","volume":"21","author":"Saunders-Pullman","year":"2003","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.neuropharm.2004.08.020_BIB38","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3171\/jns.1997.87.5.0724","article-title":"Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat","volume":"87","author":"Simpkins","year":"1997","journal-title":"J. Neurosurg"},{"issue":"26","key":"10.1016\/j.neuropharm.2004.08.020_BIB39","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1021\/jm000170m","article-title":"Pyrazole ligands: structure\u2013affinity\/activity relationships and estrogen receptor-alpha-selective agonists","volume":"43","author":"Stauffer","year":"2000","journal-title":"J. Med. Chem"},{"issue":"2","key":"10.1016\/j.neuropharm.2004.08.020_BIB40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0014-4886(03)00215-2","article-title":"Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17beta estradiol","volume":"183","author":"Struble","year":"2003","journal-title":"Exp. Neurol"},{"issue":"16","key":"10.1016\/j.neuropharm.2004.08.020_BIB41","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1073\/pnas.1531957100","article-title":"Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol","volume":"100","author":"Vegeto","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.neuropharm.2004.08.020_BIB42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/bbrc.1997.6915","article-title":"Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta","volume":"236","author":"Watanabe","year":"1997","journal-title":"Biochem. Biophys. Res. Commun"},{"issue":"1","key":"10.1016\/j.neuropharm.2004.08.020_BIB43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/frne.2000.0207","article-title":"Estrogens: trophic and protective factors in the adult brain","volume":"22","author":"Wise","year":"2001","journal-title":"Front. Neuroendocrinol"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390804002576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390804002576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T07:54:25Z","timestamp":1549094065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390804002576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0028390804002576"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2004.08.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}